Delivery Order SPE2DB20D3101-SPE2DB25FRGN5
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,308.31 firm fixed price delivery order is for the supply of Bydureon Bcise, a 2 mg autoinjected medication used to treat type 2 diabetes. The contract has a completion date of June 27, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml. The award, valued at $1,677.69, is a firm-fixed-price delivery order with a completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $14,668.02, is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml, a medication used in the treatment of diabetes. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of January 5, 2024. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $6,785.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml, a medication used for the treatment of type 2 diabetes. The contract has a firm fixed price pricing type and a completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,453.28, is a Firm Fixed Price Delivery Order for the medical product "BYDUREON BCISE 2 MG AUTOINJECT 0.85ML". The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,833.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, to support military healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Bydureon BCISE 2 mg auto-injectors. The $2,649.94 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjectors. The $6,267.96 firm fixed-price contract has a completion date of July 11, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,806.27 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,334,180 units of the diabetes medication Bydureon Bcise 2 mg auto-injectors. The contract has a ceiling value of $3,140.40 and runs through November 6, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...